67 related articles for article (PubMed ID: 11302730)
1. Chimeric caspase molecules with potent cell killing activity in apoptosis-resistant cells.
Shearwin-Whyatt L; Baliga B; Doumanis J; Kumar S
Biochem Biophys Res Commun; 2001 Apr; 282(5):1114-9. PubMed ID: 11302730
[TBL] [Abstract][Full Text] [Related]
2. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of fluorescent caspase substrate cleavage in intact cells and identification of novel inhibitors of apoptosis.
Tawa P; Tam J; Cassady R; Nicholson DW; Xanthoudakis S
Cell Death Differ; 2001 Jan; 8(1):30-7. PubMed ID: 11313700
[TBL] [Abstract][Full Text] [Related]
4. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
Kagawa S; He C; Gu J; Koch P; Rha SJ; Roth JA; Curley SA; Stephens LC; Fang B
Cancer Res; 2001 Apr; 61(8):3330-8. PubMed ID: 11309289
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
[TBL] [Abstract][Full Text] [Related]
8. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nuclear transport of caspase-7 by its prodomain.
Yaoita Y
Biochem Biophys Res Commun; 2002 Feb; 291(1):79-84. PubMed ID: 11829465
[TBL] [Abstract][Full Text] [Related]
10. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
11. BCR/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations.
Stoklosa T; Poplawski T; Koptyra M; Nieborowska-Skorska M; Basak G; Slupianek A; Rayevskaya M; Seferynska I; Herrera L; Blasiak J; Skorski T
Cancer Res; 2008 Apr; 68(8):2576-80. PubMed ID: 18413724
[TBL] [Abstract][Full Text] [Related]
12. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
Yu C; Krystal G; Dent P; Grant S
Clin Cancer Res; 2002 Sep; 8(9):2976-84. PubMed ID: 12231544
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance.
Friedrich K; Wieder T; Von Haefen C; Radetzki S; Jänicke R; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2001 May; 20(22):2749-60. PubMed ID: 11420687
[TBL] [Abstract][Full Text] [Related]
14. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
[TBL] [Abstract][Full Text] [Related]
15. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
16. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells.
Lavallard VJ; Pradelli LA; Paul A; Bénéteau M; Jacquel A; Auberger P; Ricci JE
Cancer Res; 2009 Apr; 69(7):3013-20. PubMed ID: 19318579
[TBL] [Abstract][Full Text] [Related]
17. Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant.
Silvestri R; Marfè G; Artico M; La Regina G; Lavecchia A; Novellino E; Morgante E; Di Stefano C; Catalano G; Filomeni G; Abruzzese E; Ciriolo MR; Russo MA; Amadori S; Cirilli R; La Torre F; Sinibaldi Salimei P
J Med Chem; 2006 Sep; 49(19):5840-4. PubMed ID: 16970408
[TBL] [Abstract][Full Text] [Related]
18. Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.
Scappini B; Gatto S; Onida F; Ricci C; Divoky V; Wierda WG; Andreeff M; Dong L; Hayes K; Verstovsek S; Kantarjian HM; Beran M
Cancer; 2004 Apr; 100(7):1459-71. PubMed ID: 15042680
[TBL] [Abstract][Full Text] [Related]
19. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
[TBL] [Abstract][Full Text] [Related]
20. Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway.
Kögel D; Reimertz C; Mech P; Poppe M; Frühwald MC; Engemann H; Scheidtmann KH; Prehn JH
Br J Cancer; 2001 Nov; 85(11):1801-8. PubMed ID: 11742505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
